Walleye Capital’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-38,829
| Closed | -$316K | – | 2319 |
|
|
2024
Q3 | $316K | Sell |
38,829
-6,655
| -15% | -$54.2K | ﹤0.01% | 1522 |
|
|
2024
Q2 | $291K | Sell |
45,484
-15,600
| -26% | -$99.7K | ﹤0.01% | 1704 |
|
|
2024
Q1 | $460K | Buy |
+61,084
| New | +$460K | ﹤0.01% | 1423 |
|
|
2023
Q2 | – | Sell |
-16,218
| Closed | -$189K | – | 2392 |
|
|
2023
Q1 | $189K | Sell |
16,218
-86,451
| -84% | -$1.01M | ﹤0.01% | 1342 |
|
|
2022
Q4 | $1.09M | Sell |
102,669
-221,298
| -68% | -$2.35M | 0.02% | 684 |
|
|
2022
Q3 | $3.14M | Buy |
323,967
+311,466
| +2,492% | +$3.02M | 0.06% | 310 |
|
|
2022
Q2 | $181K | Buy |
+12,501
| New | +$181K | 0.01% | 1527 |
|
|
2021
Q4 | – | Sell |
-5,388
| Closed | -$269 | – | 2125 |
|
|
2021
Q3 | $269 | Sell |
5,388
-11,861
| -69% | -$592 | 0.01% | 1041 |
|
|
2021
Q2 | $957 | Buy |
+17,249
| New | +$957 | 0.03% | 449 |
|
|
2021
Q1 | – | Sell |
-7,500
| Closed | -$326 | – | 1231 |
|
|
2020
Q4 | $326 | Buy |
+7,500
| New | +$326 | 0.02% | 590 |
|